Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Teresa Welch

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Orthopedic Nursing|December 4, 2025
The Use of an Enhanced Recovery Bundle in Surgical Spine Patients to Reduce Opioid Requirements and Improve Patient ComfortKierste Schafer, Teresa Welch
Professional Case Management|August 27, 2024
Reducing 30-day Acute Care Readmissions for Heart Failure Patients Through Implementation of a Discharge BundleJason Lindsey, Teresa Welch
The Journal of Nursing Administration|June 19, 2026
Bridging the Gap in Nursing Leadership Preparation: Aligning Educational Pathways With Functional Leadership RolesSandra Galura, Teresa Welch
Journal of Applied Behavior Analysis|October 12, 2013
Fading a concurrent activity during self-control training for children with autismKaitlynn M Gokey, David A Wilder, Teresa Welch, et al.
The Journal of Steroid Biochemistry and Molecular Biology|November 26, 2009
Vitamin D inhibition of pro-fibrotic effects of transforming growth factor beta1 in lung fibroblasts and epithelial cellsAllan M Ramirez, Cherry Wongtrakool, Teresa Welch, et al.
Nursing Administration Quarterly|August 29, 2023
Nursing Faculty Workforce Development ProjectSusan Welch, Kristi Acker, Wanda Burton, et al.
Pediatrics|April 13, 2011
Vaccines are not associated with metabolic events in children with urea cycle disordersThomas M Morgan, Cameron Schlegel, Kathryn M Edwards, et al.
Molecular Genetics and Metabolism|March 31, 2012
Peptide tyrosine tyrosine levels are increased in patients with urea cycle disordersSabrina Mitchell, Teresa Welch-Burke, Logan Dumitrescu, et al.
Journal of Medicinal Chemistry|March 3, 2006
Discovery of S-[5-amino-1-(4-fluorophenyl)-1H-pyrazol-4-yl]-[3-(2,3-dihydroxypropoxy)phenyl]methanone (RO3201195), an orally bioavailable and highly selective inhibitor of p38 MAP kinaseDavid M Goldstein, Tom Alfredson, Jay Bertrand, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Orthopedic Nursing|December 4, 2025
The Use of an Enhanced Recovery Bundle in Surgical Spine Patients to Reduce Opioid Requirements and Improve Patient ComfortKierste Schafer, Teresa Welch
Professional Case Management|August 27, 2024
Reducing 30-day Acute Care Readmissions for Heart Failure Patients Through Implementation of a Discharge BundleJason Lindsey, Teresa Welch
The Journal of Nursing Administration|June 19, 2026
Bridging the Gap in Nursing Leadership Preparation: Aligning Educational Pathways With Functional Leadership RolesSandra Galura, Teresa Welch
Journal of Applied Behavior Analysis|October 12, 2013
Fading a concurrent activity during self-control training for children with autismKaitlynn M Gokey, David A Wilder, Teresa Welch, et al.
The Journal of Steroid Biochemistry and Molecular Biology|November 26, 2009
Vitamin D inhibition of pro-fibrotic effects of transforming growth factor beta1 in lung fibroblasts and epithelial cellsAllan M Ramirez, Cherry Wongtrakool, Teresa Welch, et al.
Nursing Administration Quarterly|August 29, 2023
Nursing Faculty Workforce Development ProjectSusan Welch, Kristi Acker, Wanda Burton, et al.
Pediatrics|April 13, 2011
Vaccines are not associated with metabolic events in children with urea cycle disordersThomas M Morgan, Cameron Schlegel, Kathryn M Edwards, et al.
Molecular Genetics and Metabolism|March 31, 2012
Peptide tyrosine tyrosine levels are increased in patients with urea cycle disordersSabrina Mitchell, Teresa Welch-Burke, Logan Dumitrescu, et al.
Journal of Medicinal Chemistry|March 3, 2006
Discovery of S-[5-amino-1-(4-fluorophenyl)-1H-pyrazol-4-yl]-[3-(2,3-dihydroxypropoxy)phenyl]methanone (RO3201195), an orally bioavailable and highly selective inhibitor of p38 MAP kinaseDavid M Goldstein, Tom Alfredson, Jay Bertrand, et al.
Pageof 1